CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis
Fecha de publicación:
2019
Versión del editor:
Citación:
Bladder Cancer, 5(2), p. 159-169 (2019); doi:10.3233/BLC-180206
Descripción física:
p. 159-169
ISSN:
DOI:
Patrocinado por:
The work was partially supported by Fondo de Investigaciones Sanitarias (FIS, #PI00-0745, #PI05-1436, and #PI06-1614) and Red Tematica ´ de Investigacion Cooperativa en C ´ ancer (RTICC, ´ #RD12/0036/0050 and #RD12/0036/0034), Instituto de Salud Carlos III; and Asociacion Espa ´ nola ˜ Contra el Cancer (AECC), Spain; the Intramu- ´ ral Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA (Contract NCI NO2-CP-11015); and EU-FP7-HEALTH-F2-2008-201663-UROMOL and EU-7FP-HEALTH-TransBioBC #601933. AML was funded by a fellowship of the European Urological Scholarship Program from the European Association of Urology (EUSP Scholarship S-01-2013).
Colecciones
- Artículos [36307]
- Investigaciones y Documentos OpenAIRE [7936]
- Medicina [934]
Ficheros en el ítem
Métricas
Compartir
Estadísticas de uso
Metadatos
Este ítem está sujeto a una licencia Creative Commons